NEUMORA THERAPEUTICS INC (NMRA)

US6409791000 - Common Stock

15.6  +0.09 (+0.58%)

After market: 15.6 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to NMRA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 24.48. This target is 56.92% above the current price.
NMRA was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about NMRA.
In the previous month the buy percentage consensus was at a similar level.
NMRA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 15.6020.2023.9724.4830.45 - 29.49% 53.65% 56.92% 95.19%
Up and Down Grades
Date Firm Action Rating
2024-10-01 HC Wainwright & Co. Initiate Buy
2024-09-12 Needham Reiterate Buy -> Buy
2024-09-04 RBC Capital Reiterate Outperform -> Outperform
2024-08-07 Needham Reiterate Buy -> Buy
2024-07-22 Needham Initiate Buy
2024-07-08 Mizuho Initiate Outperform
2024-03-28 RBC Capital Reiterate Outperform -> Outperform
2024-03-18 JP Morgan Maintains Overweight -> Overweight
2024-03-08 RBC Capital Maintains Outperform -> Outperform
2023-11-08 JP Morgan Maintains Overweight -> Overweight
2023-10-10 Guggenheim Initiate Buy
2023-10-10 William Blair Initiate Outperform
2023-10-10 RBC Capital Initiate Outperform
2023-10-10 Stifel Initiate Buy
2023-10-10 JP Morgan Initiate Overweight
2023-10-10 B of A Securities Initiate Buy